FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to biochemistry, particularly to a composition for immunostimulation. There are disclosed an adjuvant pharmaceutical composition and a vaccine containing said composition for immunostimulation. Also disclosed are the use of the composition for immunostimulation when preparing a vaccine; methods of preventing or treating a viral infection using said composition.
EFFECT: invention enables effective immunostimulation.
17 cl, 9 tbl, 15 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITIONS OF GLYCOPROTEIN G OF HENDRA AND NIPAH VIRUSES | 2012 |
|
RU2787820C2 |
| VECTORS FOR EXPRESSION OF PROSTATE-ASSOCIATED ANTIGENS | 2014 |
|
RU2650860C2 |
| COMPOSITIONS OF IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATES AND USE THEREOF | 2015 |
|
RU2720295C2 |
| LIPOSOMAL ADJUVANT COMPOSITIONS | 2016 |
|
RU2736642C2 |
| BIOLOGICAL MATERIALS FOR MODULATING IMMUNE RESPONSES | 2017 |
|
RU2770060C2 |
| FUSION PROTEIN | 2016 |
|
RU2748643C2 |
| ADVANCED CORONAVIRUS VACCINE | 2022 |
|
RU2816182C2 |
| METHODS AND COMPOSITIONS FOR INDUCTION OF IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE | 2018 |
|
RU2781057C2 |
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
